Showing results (1-10 of 313) with videos related to
Sort By:
Pageof 32
Pediatric Nephrology (Berlin, Germany)|July 27, 2000
Growth hormone axis overview--somatomedin hypothesisW H DaughadayEndocrinology and Metabolism Clinics of North America|September 1, 1992
Pituitary gigantismW H DaughadayEndocrinology and Metabolism Clinics of North America|March 1, 1989
Hypoglycemia in patients with non-islet cell tumorsW H DaughadayThe Journal of Clinical Endocrinology and Metabolism|August 1, 1992
Heterogeneity of serum peptides with immunoactivity detected by a radioimmunoassay for proinsulin-like growth factor-II E domain: description of a free E domain peptide in serumW H Daughaday, B TrivediEndocrinology|April 1, 1978
Maintenance of serum somatomedin activity in hypophysectomized pregnant ratsW H Daughaday, M KapadiaThe Journal of Clinical Endocrinology and Metabolism|July 1, 1992
Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemiaW H Daughaday, B TrivediProceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism)W H Daughaday, B TrivediDiabetes|September 1, 1975
Marked hyperthermia as a manifestation of hypoglycemia in long-standing diabetes mellitusR Chochinov, W H DaughadayEndocrine Reviews|February 1, 1989
Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrationsW H Daughaday, P RotweinProceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumorsW H Daughaday, M KapadiaPageof 32